DGX
QUEST DIAGNOSTICS INC
NYSE: DGX · Secaucus, NJ · Healthcare
$241.89-1.39 (-0.57%)Closed
Market Cap$26.61B
Cash$797.0Mmost recent
Runwayprofitable
P/E (TTM)27.6EPS $8.75
52-Wk Range$170.62 – $246.53
Avg Volume994.2K3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$241.89+58.6%
Pipeline
Drug candidates sponsored by QUEST DIAGNOSTICS · ClinicalTrials.gov
| Phase | Drug / Candidate | Indications | Status | Next Completion | Trials | |
|---|---|---|---|---|---|---|
| N/A | cfDNA analysis | Early Pregnancy Loss | Terminated | 2022-12-31past | 1 |
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for DGX. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.